Corpus Intelligence IC Memo — MBH OF NORTHERN ARIZONA 2026-04-26 09:36 UTC
IC Memo — MBH OF NORTHERN ARIZONA
Investment Committee Memorandum | AZ | 24 beds | Grade D | EBITDA uplift $226K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MBH OF NORTHERN ARIZONA

CCN 034036 | YAVAPAI, AZ | 24 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MBH OF NORTHERN ARIZONA is a 24-bed community hospital in YAVAPAI, AZ with $2.9M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 26.9% Medicare, 0.0% Medicaid, and 73.1% commercial.

Thesis: Turnaround. Our ML models identify $226K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -95.2% (+786bps).

Net Revenue HCRIS$2.9M
Current EBITDA COMPUTED$-3.0M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS52.7%
Revenue / Bed COMPUTED$120K
Net-to-Gross HCRIS41.9%
Distress Probability MLnan%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
38
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -100.0% places it below the state median. Among 38 size-comparable peers (12-48 beds), the median margin is -0.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MBH OF NORTHERN ARIZONA (Target)AZ24$2.9M-100.0%
ARIZONA GENERAL HOSPITALAZ16$97.1M10.4%
THE CORE INSTITUTE SPECIALTY HAZ28$91.2M9.2%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$75.2M-2.8%
COBRE VALLEY REG. MEDICAL CENTAZ25$74.9M-10.3%
COPPER QUEEN COMM. HOSP.AZ14$63.5M6.6%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$49.4M-6.8%
BANNER PAYSON MEDICAL CENTERAZ25$49.3M0.0%
AZ SPINE & JOINT HOSPITALAZ23$45.1M19.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $226K (786bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$64K+221bp12mo
Net Collection Rate93.5%97.0%$60K+210bp18mo
Cost to Collect4.5%2.5%$58K+200bp12mo
A/R Days Reduction5200.0%3800.0%$35K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+33bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$64K
Net Collection Rate
$60K
Cost to Collect
$58K
A/R Days Reduction
$35K
Clean Claim Rate
$10K
Total EBITDA Uplift$226K
Current EBITDA$-3.0M
+ RCM Uplift+$226K
Pro Forma EBITDA$-2.7M
Current Margin-100.0%
Pro Forma Margin-95.2%
WC Released (1x)$110K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.6M$-17.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.6M$-20.5M0.00x-100.0%
Bull Case9.0x11.0x$-4.1M$-21.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.1M$-24.4M0.00x-100.0%
Bear Case11.0x10.0x$-5.0M$-17.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.0M$-20.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 12-48 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-9.8% / P50=-0.7% / P75=8.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.